ArticleFrontiers in psychiatry2026
Transcutaneous auricular vagus nerve stimulation, tolerability, and the Alpha/Theta EEG ratio: a controlled pilot study relevant to emotion regulation.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anxiety and depression are both characterised by difficulties in emotion regulation, associated with altered cortical oscillatory activity. Transcutaneous auricular vagus nerve stimulation (taVNS) may modulate these dynamics, but few studies have examined stimulation intensity alongside both tolerability and EEG outcomes. Methods: In this controlled pilot, ten healthy female adults (21.1 ± 1.8 years) were randomized to taVNS (n = 5) or a waitlist control (n = 5). The taVNS group completed eight 30-minute left tragus sessions over four weeks (20 Hz, 200 μs, 14-25 mA, individually titrated), with Alpha/Theta and Theta/Beta ratios derived from resting-state EEG at Cz. We applied False Discovery Rate (FDR) correction across the exploratory comparisons. Results: Protocol completion was 100% across 40 sessions. Of 39 stimulation-related observations, 29 were tolerability or adverse-event symptoms, predominantly CTCAE Grade 1 (86.2%); 10 were self-reported sensations of pulse change, recorded separately. None was serious. Within-group change in the taVNS group was not significant (exact p = .063 for both ratios). Stimulation intensity did not show a positive dose-response. Between-group comparisons of change scores favoured taVNS for both ratios (both U = 25, exact p = .008; Hodges-Lehmann median difference 0.56, 95% CI [0.12, 0.90] for Alpha/Theta) and remained significant after FDR correction. Conclusion: The protocol was completed by all five stimulated participants without serious adverse events under individual titration to tolerability (14-25 mA). We found preliminary effects on an EEG index relevant to emotion regulation, providing a quantitative basis for powering sham-controlled trials in clinical emotional dysregulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.